Therapeutic Evaluation of Epstein-Barr Virus-encoded Latent Membrane Protein-1 Targeted DNAzyme for Treating of Nasopharyngeal Carcinomas

The ability of the 10–23 DNAzyme to specifically cleave RNA with high efficiency has fuelled expectation that this agent may have useful applications for targeted therapy. Here, we, for the first time, investigated the antitumor and radiosensitizing effects of a DNAzyme (DZ1) targeted to the Epstein...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Cao, Ya, Yang, Lifang, Jiang, Wuzhong, Wang, Xiaoyi, Liao, Weihua, Tan, Guolin, Liao, Yuping, Qiu, Yuanzheng, Feng, Deyun, Tang, Faqing, Hou, Bob L, Zhang, Ling, Fu, Jia, He, Fengjiao, Liu, Xiaoyu, Jiang, Wenjuan, Yang, Tubao, Sun, Lun-Quan
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2014
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3916047/
https://ncbi.nlm.nih.gov/pubmed/24322331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2013.257
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires